サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1655315

鉄欠乏性貧血治療の世界市場

Iron Deficiency Anemia Therapy

出版日
ページ情報
英文 192 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
鉄欠乏性貧血治療の世界市場
出版日: 2025年02月14日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 192 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

鉄欠乏性貧血治療の世界市場は2030年までに239億米ドルに達する見込み

2024年に154億米ドルと推定される鉄欠乏性貧血治療の世界市場は、分析期間2024-2030年にCAGR 7.6%で成長し、2030年には239億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである経口鉄剤療法は、CAGR 6.9%を記録し、分析期間終了時には111億米ドルに達すると予測されます。非経口鉄療法分野の成長率は、分析期間中CAGR 8.5%と推定されます。

米国市場は40億米ドルと推定、中国はCAGR11.0％で成長予測

米国の鉄欠乏性貧血治療市場は2024年に40億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに58億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは11.0%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.9%と6.8%と予測されています。欧州では、ドイツがCAGR 4.5%で成長すると予測されています。

世界の鉄欠乏性貧血治療市場動向と将来展望

なぜ鉄欠乏性貧血は世界の健康問題なのか？

鉄欠乏性貧血（IDA）は世界的に最も一般的な栄養欠乏症の一つであり、特に女性、子供、高齢者を中心に数百万人が罹患しています。この症状は、体内でヘモグロビンを生成するのに十分な鉄分が不足することで起こり、疲労、衰弱、その他の健康合併症を引き起こします。IDAは、鉄分の豊富な食品やヘルスケアへのアクセスが限られている開発途上地域に特に多く見られます。しかし、食習慣や慢性疾患、ある種の薬剤が鉄欠乏の一因となりうる先進諸国においても、鉄欠乏は重大な懸念事項です。未治療の貧血は、認知機能の低下、労働能力の低下、妊産婦や乳児の死亡リスクの増加など、重篤な合併症を引き起こす可能性があるため、IDAに対処することは公衆衛生のアウトカムを改善する上で極めて重要です。

治療の進歩は鉄欠乏性貧血患者の予後をどのように改善しているか？

鉄欠乏性貧血治療の進歩は、より効果的で便利な治療法を提供することで、患者の予後を改善しています。従来の経口鉄サプリメントは広く使用されているが、消化器系の副作用を引き起こす可能性があり、重度の貧血や吸収不良の問題を抱える患者の鉄レベル回復には必ずしも有効ではないです。最近の点滴静注療法の動向は、このような患者に代替療法を提供し、より少ない副作用で鉄貯蔵量を迅速に補充することを可能にしています。さらに、吸収性と忍容性を高めた経口鉄剤の新しい製剤が利用できるようになり、患者のコンプライアンスと治療成績が向上しています。鉄サプリメントとビタミンCやその他の鉄吸収促進剤との併用療法なども、治療効果を高めるために検討されています。

先進的鉄欠乏性貧血治療の普及を阻む課題とは？

先進的な治療法があるにもかかわらず、いくつかの課題がその普及を妨げています。大きな課題のひとつは、高価で、臨床環境での投与が必要な静脈内鉄剤治療のコストと利用しやすさです。そのため、重度の貧血患者や経口サプリメントに反応しない患者への使用が制限されています。加えて、IDAの早期診断と早期治療の重要性に対する患者やヘルスケアプロバイダーの認識不足が、治療の遅れにつながっています。もう一つの課題は、鉄療法に対する反応のばらつきです。基礎疾患や治療へのアドヒアランス不良のために、望ましい結果が得られない患者もいるからです。これらの課題に対処するには、的を絞った教育的取り組み、手頃な価格の治療薬へのアクセス改善、さまざまな患者集団に治療レジメンを最適化するための継続的研究が必要です。

鉄欠乏性貧血治療市場の成長を促進する要因は？

鉄欠乏性貧血治療市場の成長は、貧血の有病率の増加、治療法の進歩、貧血に対する意識の高まりなど、いくつかの要因によって牽引されています。貧血の原因となる腎臓病や炎症性腸疾患などの慢性疾患の罹患率が上昇していることも、効果的な治療法の需要に寄与しています。さらに、特に発展途上地域において母子の健康への関心が高まっていることも、入手しやすく手頃な価格の鉄サプリメントへのニーズを後押ししています。ヘルスケア・インフラの拡大や、改良された経口・静脈鉄製剤などの新たな治療オプションの利用可能性が、市場の成長をさらに後押ししています。IDAとその健康への影響に対する認識が高まるにつれて、診断と治療を求める個人が増え、さまざまな治療オプションに対する需要を促進しています。

セグメント

治療タイプ（経口鉄療法、非経口鉄療法、赤血球輸血）

調査対象企業の例（全38件）

  • Allergan PLC
  • AMAG Pharmaceuticals, Inc.
  • Johnson & Johnson
  • Keryx Biopharmaceuticals, Inc.
  • Luitpold Pharmaceuticals, Inc.
  • Pharmacosmos A/S
  • Pieris Pharmaceuticals, Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP12863

Global Iron Deficiency Anemia Therapy Market to Reach US$23.9 Billion by 2030

The global market for Iron Deficiency Anemia Therapy estimated at US$15.4 Billion in the year 2024, is expected to reach US$23.9 Billion by 2030, growing at a CAGR of 7.6% over the analysis period 2024-2030. Oral Iron Therapy, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$11.1 Billion by the end of the analysis period. Growth in the Parenteral Iron Therapy segment is estimated at 8.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$4.0 Billion While China is Forecast to Grow at 11.0% CAGR

The Iron Deficiency Anemia Therapy market in the U.S. is estimated at US$4.0 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$5.8 Billion by the year 2030 trailing a CAGR of 11.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.9% and 6.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.

Global Iron Deficiency Anemia Therapy Market - Trends & Future Prospects

Why Is Iron Deficiency Anemia a Global Health Concern?

Iron deficiency anemia (IDA) is one of the most common nutritional deficiencies worldwide, affecting millions of people, particularly women, children, and the elderly. This condition occurs when the body lacks sufficient iron to produce hemoglobin, leading to fatigue, weakness, and other health complications. IDA is particularly prevalent in developing regions, where access to iron-rich foods and healthcare is limited. However, it is also a significant concern in developed countries, where dietary habits, chronic illnesses, and certain medications can contribute to iron deficiency. Addressing IDA is crucial for improving public health outcomes, as untreated anemia can lead to severe complications, including impaired cognitive function, reduced work capacity, and increased risk of maternal and infant mortality.

How Are Advances in Therapy Improving Outcomes for Iron Deficiency Anemia Patients?

Advances in iron deficiency anemia therapy are improving outcomes for patients by offering more effective and convenient treatment options. Traditional oral iron supplements, while widely used, can cause gastrointestinal side effects and are not always effective in restoring iron levels in patients with severe anemia or malabsorption issues. Recent developments in intravenous (IV) iron therapies provide an alternative for these patients, offering rapid replenishment of iron stores with fewer side effects. Additionally, new formulations of oral iron supplements with enhanced absorption and tolerability are becoming available, improving patient compliance and outcomes. The use of combination therapies, such as iron supplements with vitamin C or other enhancers of iron absorption, is also being explored to boost the efficacy of treatments.

What Challenges Are Hindering the Widespread Adoption of Advanced Iron Deficiency Anemia Therapies?

Despite the availability of advanced therapies, several challenges hinder their widespread adoption. One major challenge is the cost and accessibility of IV iron treatments, which can be expensive and require administration in a clinical setting. This limits their use to patients with severe anemia or those who do not respond to oral supplements. Additionally, there is a lack of awareness among patients and healthcare providers about the importance of early diagnosis and treatment of IDA, leading to delays in care. Another challenge is the variability in response to iron therapy, as some patients may not achieve the desired outcomes due to underlying conditions or poor adherence to treatment. Addressing these challenges requires targeted educational initiatives, improved access to affordable treatments, and ongoing research to optimize therapy regimens for different patient populations.

What Factors Are Driving the Growth of the Iron Deficiency Anemia Therapy Market?

The growth of the iron deficiency anemia therapy market is driven by several factors, including the increasing prevalence of anemia, advancements in treatment options, and greater awareness of the condition. The rising incidence of chronic diseases, such as kidney disease and inflammatory bowel disease, which can lead to anemia, is also contributing to the demand for effective therapies. Additionally, the growing focus on maternal and child health, particularly in developing regions, is driving the need for accessible and affordable iron supplements. The expansion of healthcare infrastructure and the availability of new treatment options, such as improved oral and IV iron formulations, are further supporting market growth. As awareness of IDA and its health implications increases, more individuals are seeking diagnosis and treatment, driving demand for a range of therapeutic options.

SCOPE OF STUDY:

The report analyzes the Iron Deficiency Anemia Therapy market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Therapy Type (Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 38 Featured) -

  • Allergan PLC
  • AMAG Pharmaceuticals, Inc.
  • Johnson & Johnson
  • Keryx Biopharmaceuticals, Inc.
  • Luitpold Pharmaceuticals, Inc.
  • Pharmacosmos A/S
  • Pieris Pharmaceuticals, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Iron Deficiency Anemia Therapy - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Iron Deficiency Anemia Spurs Growth in Therapy Market
    • Advancements in Oral Iron Supplements Propel Innovation in Anemia Treatment
    • Growing Demand for Intravenous (IV) Iron Therapies Expands Addressable Market
    • Shift Towards Non-Invasive Treatment Options Strengthens Business Case for New Therapies
    • Increased Focus on Early Diagnosis and Screening Drives Adoption of Anemia Therapies
    • Technological Innovations in Drug Delivery Systems Accelerate Demand for Advanced Therapies
    • Rising Awareness Campaigns on Iron Deficiency Throws Spotlight on Treatment Options
    • Expanding Applications of Iron Supplementation in Pregnant Women Generate New Opportunities
    • Shift Towards Personalized Medicine in Anemia Treatment Drives Market Innovation
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Iron Deficiency Anemia Therapy Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Iron Deficiency Anemia Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Iron Deficiency Anemia Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Oral Iron Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Oral Iron Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Oral Iron Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Parenteral Iron Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Parenteral Iron Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Parenteral Iron Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Red Blood Cell Transfusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Red Blood Cell Transfusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Red Blood Cell Transfusion by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Iron Deficiency Anemia Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 14: USA Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 15: USA Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: USA 15-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 17: Canada Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 18: Canada Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: Canada 15-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2015, 2025 & 2030
  • JAPAN
    • Iron Deficiency Anemia Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: Japan Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: Japan 15-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2015, 2025 & 2030
  • CHINA
    • Iron Deficiency Anemia Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 23: China Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 24: China Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: China 15-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2015, 2025 & 2030
  • EUROPE
    • Iron Deficiency Anemia Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Iron Deficiency Anemia Therapy by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: Europe 15-Year Perspective for Iron Deficiency Anemia Therapy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: Europe 15-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2015, 2025 & 2030
  • FRANCE
    • Iron Deficiency Anemia Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 32: France Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: France Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: France 15-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2015, 2025 & 2030
  • GERMANY
    • Iron Deficiency Anemia Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 35: Germany Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Germany Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Germany 15-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 38: Italy Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Italy Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Italy 15-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Iron Deficiency Anemia Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 41: UK Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: UK Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: UK 15-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 44: Spain Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Spain Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Spain 15-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 47: Russia Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Russia Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Russia 15-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Rest of Europe Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Rest of Europe 15-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Iron Deficiency Anemia Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Iron Deficiency Anemia Therapy by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Asia-Pacific 15-Year Perspective for Iron Deficiency Anemia Therapy by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Asia-Pacific 15-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Iron Deficiency Anemia Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 59: Australia Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Australia Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Australia 15-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2015, 2025 & 2030
  • INDIA
    • Iron Deficiency Anemia Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 62: India Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: India Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: India 15-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 65: South Korea Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: South Korea Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: South Korea 15-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 68: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Rest of Asia-Pacific Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Rest of Asia-Pacific 15-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Iron Deficiency Anemia Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Iron Deficiency Anemia Therapy by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Latin America 15-Year Perspective for Iron Deficiency Anemia Therapy by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 74: Latin America Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Latin America Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Latin America 15-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 77: Argentina Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Argentina Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Argentina 15-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 80: Brazil Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Brazil Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Brazil 15-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 83: Mexico Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Mexico Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Mexico 15-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 86: Rest of Latin America Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Latin America Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Rest of Latin America 15-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Iron Deficiency Anemia Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for Iron Deficiency Anemia Therapy by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Middle East 15-Year Perspective for Iron Deficiency Anemia Therapy by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 92: Middle East Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Middle East Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Middle East 15-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 95: Iran Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Iran Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Iran 15-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 98: Israel Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Israel Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Israel 15-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 101: Saudi Arabia Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Saudi Arabia Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Saudi Arabia 15-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 104: UAE Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UAE Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: UAE 15-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 107: Rest of Middle East Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Rest of Middle East Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Rest of Middle East 15-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2015, 2025 & 2030
  • AFRICA
    • Iron Deficiency Anemia Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 110: Africa Recent Past, Current & Future Analysis for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Africa Historic Review for Iron Deficiency Anemia Therapy by Therapy Type - Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Africa 15-Year Perspective for Iron Deficiency Anemia Therapy by Therapy Type - Percentage Breakdown of Value Sales for Oral Iron Therapy, Parenteral Iron Therapy and Red Blood Cell Transfusion for the Years 2015, 2025 & 2030

IV. COMPETITION